Rodent research suggests feasibility of restoring neuron function
Research from the School of Medicine at The University of Texas Health Science Center at San Antonio suggests the exciting possibility of using cell transplants to treat schizophrenia.
Cells called “interneurons” inhibit activity within brain regions, but this braking or governing function is impaired in schizophrenia. Consequently, a group of nerve cells called the dopamine system go into overdrive. Different branches of the dopamine system are involved in cognition, movement and emotions.
“Since these cells are not functioning properly, our idea is to replace them,” said study senior author Daniel Lodge, Ph.D., assistant professor of pharmacology in the School of Medicine.
Transplant restored normal function
Dr. Lodge and lead author Stephanie Perez, graduate student in his laboratory, biopsied tissue from rat fetuses, isolated cells from the tissue and injected the cells into a brain center called the hippocampus. This center regulates the dopamine system and plays a role in learning, memory and executive functions such as decision making. Rats treated with the transplanted cells have restored hippocampal and dopamine function.
Stem cells are able to become different types of cells, and in this case interneurons were selected. “We put in a lot of cells and not all survived, but a significant portion did and restored hippocampal and dopamine function back to normal,” Dr. Lodge said.
‘You can essentially fix the problem’
Unlike traditional approaches to treating schizophrenia, such as medications and deep-brain stimulation, transplantation of interneurons potentially can produce a permanent solution. “You can essentially fix the problem,” Dr. Lodge said. “Ultimately, if this is translated to humans, we want to reprogram a patient’s own cells and use them.”
The Latest on: Schizophrenia
- Bacterial infections in pregnancy may make schizophrenia more likelyon October 18, 2019 at 11:33 pm
Children of mothers who had bacterial infections during pregnancy are more likely to develop mental health conditions like schizophrenia and bipolar disorder. We already knew that exposure to viruses ...
- Boy With Paranoid Schizophrenia Found In Culver Cityon October 18, 2019 at 9:24 am
(Culver City Police Department) CULVER CITY, CA — A missing Culver City boy who suffers from paranoid schizophrenia and has a history of attempted suicide has been found, police said Friday. Ignatz ...
- Attention-deficit hyperactivity disorder shares copy number variant risk with schizophrenia and autism spectrum disorderon October 17, 2019 at 10:13 am
Follow-up studies of children have documented the persistence of ADHD symptoms into adulthood in approximately two-thirds of patients 3. Studies have focused on the relationship between ADHD and ...
- Indianapolis man with schizophrenia fatally stabs mother 21 times in argument over ‘inheritance’on October 17, 2019 at 6:05 am
An Indiana man with schizophrenia who allegedly stabbed his mother to death, tussled over the knives with his brother, and escaped only to be shot in the leg by his mother’s boyfriend is in custody ...
- Chromatin profiling of cortical neurons identifies individual epigenetic signatures in schizophreniaon October 17, 2019 at 5:28 am
Schizophrenia (SZ) is a complex disorder with highly variable clinical manifestations of psychotic symptoms, such as auditory hallucinations, paranoid or bizarre delusions, disorganized thinking, and ...
- First Schizophrenia Patch OK'd; Dementia-Related Agitation Therapieson October 16, 2019 at 3:04 pm
The first once-daily transdermal patch for schizophrenia -- containing the atypical antipsychotic asenapine -- gained FDA approval this week and will be sold under the name Secuado, said Noven ...
- Researchers glean new insights into biological underpinnings of schizophreniaon October 16, 2019 at 4:12 am
Researchers have implicated 10 new genes in the development of schizophrenia using a method called whole exome sequencing, the analysis of the portion of DNA that codes for proteins. Working with a ...
- New Schizophrenia Drug Approved by FDA, Will Be Available as Transdermal Patchon October 15, 2019 at 3:45 pm
The first transdermal patch used to treat schizophrenia has been approved by the U.S. Food and Drug Administration. The medication, asenapine, manufactured by Hisamitsu Pharmaceutical, will be ...
- FDA Clears First Transdermal Patch for Schizophreniaon October 15, 2019 at 9:28 am
The US Food and Drug Administration (FDA) has approved a transdermal patch formulation of the atypical antipsychotic asenapine (Secuado, Noven Pharmaceuticals) for the treatment of adults with ...
- Scientists Reverse Core Symptom of Schizophrenia in Adult Miceon October 14, 2019 at 6:04 am
Columbia researchers have restored normal working memory to a mouse model of schizophrenia, eliminating a core symptom of the disorder that, in people, has proven virtually impossible to treat.
via Google News and Bing News